CIC
CLBT icon

Chilton Investment Company’s Cellebrite CLBT Stock Holding History

Chilton Investment Company’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-41,651
Closed -$918K – 210
2024
Q4 		$918K Sell
41,651
-3,340
-7% -$64.3K 0.02% 109
2024
Q3 		$758K Buy
+44,991
New +$668K 0.02% 125

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chilton Investment Company's CLBT Position: Q1 2025 in Review

Chilton Investment Company sold out of Cellebrite (CLBT) in Q1 2025, closing a stake of 41,651 shares — an estimated $918K sold.

Chilton Investment Company first reported a position in CLBT in Q3 2024 and held it in 2 quarters. The position peaked at $918K in Q4 2024. 199 funds tracked by Wall St. Rank hold CLBT as of Q1 2025.

  • Chilton Investment Company reported no remaining Cellebrite position as of Q1 2025 after selling out during the quarter.
  • Chilton Investment Company sold 41,651 Cellebrite shares in Q1 2025, an estimated $918K.
  • Chilton Investment Company first reported a position in Cellebrite in Q3 2024 and held it in 2 quarters.
  • Chilton Investment Company's Cellebrite position peaked at $918K in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Cellebrite as of Q1 2025.

Based on Chilton Investment Company's 13F filing for Q1 2025, filed 15 May 2025.